Welcome to Antibodies.cancer.gov - Antibody Portal | Office of Cancer Clinical Proteomics Research

antibodies.cancer.gov

Description: Antibodies Cancer. Central to reproducibility in biomedical research is being able to use well-characterized and defined reagents. The CPTAC Antibody...

Google PR 5

Trustworthiness Excellent
Avg. Daily Visitors N/A

Child Safety Excellent
Avg. Daily Pageviews N/A

Privacy Excellent

Antibody Portal | Office of Cancer Clinical Proteomics Research

Antibodies.cancer.gov: get to the top rated Antibodies Cancer pages and content popular with USA-based Antibodies.cancer.gov users or check the following digest to find out more. Antibodies.cancer.gov is a malware-free website without age restrictions, so you can safely browse it. It seems that Antibodies Cancer team are just starting to conquer the social media and they have already achieved a promising result — 41 user activities so far (StumbleUpon dominates with around 98% of all user reactions). Antibodies.cancer.gov is hosted with National Cancer Institute in United States. Antibodies Cancer traffic is not yet estimated by Alexa.

Visit antibodies.cancer.gov

Domain info

Location:	United States
Registrant:	REDACTED FOR PRIVACY
Hosted by:	National Cancer Institute
Subnetworks:	129.43.40.106

Social Media Activities

Facebook likes: -
Twitter mentions: 1
Google pluses: -
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: 40

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Antibodies.cancer.gov popular pages to visit

Antibody Portal | Office of Cancer Clinical Proteomics Research Central to reproducibility in biomedical research is being able to use well-characterized and defined reagents. The CPTAC Antibody Portal serves as a National Cancer Institute (NCI) community resource...

The Clinical Proteomic Technologies for Cancer | Details for Melanoma+Antigen+Family+A%2C+4 An objective of the Reagents and Resources component of NCI's Clinical Proteomic Technologies for Cancer Initiative is to generate highly characterized monoclonal antibodies to human proteins associat...

The Clinical Proteomic Technologies for Cancer | Details for CPTC-PSMD4-3 Function: The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 n...